← Back to all recalls
DRUG RECALLMODERATE
Lanreotide Injection 120 mg/0.5 mL
Cipla is recalling Lanreotide Injection 120 mg/0.5 mL (NDC 69097-870-67) due to particulate matter contamination.
What to do
Do not use this medication. Contact your healthcare provider or pharmacist immediately to report receipt of this product and obtain a replacement. Return the affected syringe to your pharmacy.
Why it was recalled
Presence of Particulate Matter.
How to identify it
Lanreotide Injection, 120 mg/0.5 mL, 0.5 mL per pre-filled syringe, For deep subcutaneous injection, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-870-67
Where it was sold
Distributed nationwide.
Official source
Other recent recalls from Cipla USA, Inc.
Editorial summary by Recall Canary · last updated 2026-04-27 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification